Anlotinib as treatment for advanced non-small cell lung cancer: A systematic review and meta-analysis on overall survival and progression free survival

被引：0
|
作者：
Susanto, B. [1 ]
Marcella, E. [1 ]
Chen, S. [1 ]
Heriyanto, R. S. [1 ]
Tandiono, J. [1 ]
Wijovi, F. [1 ]
Tancherla, A. [1 ]
Kurniawan, A. [2 ]
机构：
[1] Pelita Harapan Univ, Fac Med, Tangerang, Indonesia
[2] Pelita Harapan Univ, Dept Internal Med, Tangerang, Indonesia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
172P
引用
收藏
页码：S792 / S792
页数：1
相关论文
共 50 条
  • [41] Optimal duration of chemotherapy for advanced non-small cell lung cancer: A systematic review and meta-analysis
    Soon, Yu
    Askie, Lisa
    Stockler, Martin
    Boyer, Michael
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S450 - S451
  • [42] Neoadjuvant immunotherapy for advanced, resectable non-small cell lung cancer: A systematic review and meta-analysis
    Wu, Yajing
    Verma, Vivek
    Gay, Carl M.
    Chen, Yujia
    Liang, Fei
    Lin, Qiang
    Wang, Jianing
    Zhang, Wei
    Hui, Zhouguang
    Zhao, Min
    Wang, Jun
    Chang, Joe Y.
    [J]. CANCER, 2023, 129 (13) : 1969 - 1985
  • [43] SURVIVAL AND TOXICITY ASSOCIATED WITH DOCETAXEL DOSE AND SCHEDULE FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC): SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
    Hess, L. M.
    Oton, A. B.
    Treat, J.
    Saxman, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S59 - S59
  • [44] Objective response rate and progression-free survival as surrogate endpoints for overall survival and the impact of crossover and unbalanced post-progression treatments: A systematic review and meta-analysis in second- and further-line therapy of advanced non-small cell lung cancer
    Pfeiffer, Boris
    Hashim, Mahmoud
    Bartsch, Robert
    Postma, Maarten
    Heeg, Bart
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Impact of Hormone Replacement Therapy on the Overall Survival and Progression Free Survival of Ovarian Cancer Patients: A Systematic Review and Meta-Analysis
    Achimas-Cadariu, Patriciu Andrei
    Paun, Diana Loreta
    Pasca, Andrei
    [J]. CANCERS, 2023, 15 (02)
  • [46] IMPACT OF HORMONE REPLACEMENT THERAPY ON THE OVERALL SURVIVAL AND PROGRESSION FREE SURVIVAL OF OVARIAN CANCER PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Pasca, Andrei
    Paun, Diana Loreta
    Kubelac, Paul Milan
    Gata, Vlad Alexandru
    Jiboc, Nicoleta Monica
    Vlad, Catalin Ioan
    Achimas-Cadariu, Patriciu Andrei
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A362 - A362
  • [47] Location of stage I-III non-small cell lung cancer and survival rate: Systematic review and meta-analysis
    Lee, Hyun Woo
    Lee, Chang-Hoon
    Park, Young Sik
    [J]. THORACIC CANCER, 2018, 9 (12) : 1614 - 1622
  • [48] Diabetes mellitus and survival of non-small cell lung cancer patients after surgery: A comprehensive systematic review and meta-analysis
    Deng, Han-Yu
    Zheng, Xi
    Zha, Panpan
    Peng, Lei
    Huang, Kai-Li
    Qiu, Xiao-Ming
    [J]. THORACIC CANCER, 2019, 10 (03) : 571 - 578
  • [49] The Prognostic Role of mTOR and P-mTOR for Survival in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Li, Lei
    Liu, Dan
    Qiu, Zhi-Xin
    Zhao, Shuang
    Zhang, Li
    Li, Wei-Min
    [J]. PLOS ONE, 2015, 10 (02):
  • [50] Predictors of survival to immunotherapy and chemoimmunotherapy in non-small cell lung cancer: A meta-analysis
    Federico, Alessandro Di
    Giglio, Andrea De
    Gelsomino, Francesco
    Sperandi, Francesca
    Melotti, Barbara
    Ardizzoni, Andrea
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (01) : 29 - 42
12345